Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Robbins

Showing results (221-230 of 331) with videos related to

Pageof 34
Sort By:
The Journal of Infectious Diseases|April 19, 2008
Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapyTodd Hulgan, Pablo Tebas, Jeffrey A Canter, et al.
The Journal of Infectious Diseases|July 14, 2009
Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjectsSamir K Gupta, Lauren Komarow, Roy M Gulick, et al.
Molecular Psychiatry|July 27, 2005
Alternative transcripts and evidence of imprinting of GNAL on 18p11.2J P Corradi, V Ravyn, A K Robbins, et al.
The Journal of Infectious Diseases|May 8, 2010
Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapyRobert C Kalayjian, Rhoderick N Machekano, Nesrine Rizk, et al.
Sexually Transmitted Infections|August 28, 2010
Ocular syphilis among HIV-infected patients: a systematic analysis of the literatureJoseph D Tucker, Jonathan Z Li, Gregory K Robbins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2023
Mogamulizumab for Treatment of Human T-lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Single-Center US-based SeriesEric A Meyerowitz, Shibani S Mukerji, G Kyle Harrold, et al.
Plos One|September 13, 2012
T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384Todd Hulgan, Gregory K Robbins, Spyros A Kalams, et al.
The Journal of Infectious Diseases|July 18, 2006
GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotypeCarolynne Schwarze-Zander, Jason T Blackard, Hui Zheng, et al.
AIDS (London, England)|July 19, 2006
Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapyAsha R Kallianpur, Todd Hulgan, Jeffrey A Canter, et al.
The Pharmacogenomics Journal|August 9, 2007
The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathyJ A Canter, D W Haas, A R Kallianpur, et al.
Pageof 34

Showing results (221-230 of 331) with videos related to

Sort By:
Pageof 34
The Journal of Infectious Diseases|April 19, 2008
Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapyTodd Hulgan, Pablo Tebas, Jeffrey A Canter, et al.
The Journal of Infectious Diseases|July 14, 2009
Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjectsSamir K Gupta, Lauren Komarow, Roy M Gulick, et al.
Molecular Psychiatry|July 27, 2005
Alternative transcripts and evidence of imprinting of GNAL on 18p11.2J P Corradi, V Ravyn, A K Robbins, et al.
The Journal of Infectious Diseases|May 8, 2010
Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapyRobert C Kalayjian, Rhoderick N Machekano, Nesrine Rizk, et al.
Sexually Transmitted Infections|August 28, 2010
Ocular syphilis among HIV-infected patients: a systematic analysis of the literatureJoseph D Tucker, Jonathan Z Li, Gregory K Robbins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2023
Mogamulizumab for Treatment of Human T-lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Single-Center US-based SeriesEric A Meyerowitz, Shibani S Mukerji, G Kyle Harrold, et al.
Plos One|September 13, 2012
T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384Todd Hulgan, Gregory K Robbins, Spyros A Kalams, et al.
The Journal of Infectious Diseases|July 18, 2006
GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotypeCarolynne Schwarze-Zander, Jason T Blackard, Hui Zheng, et al.
AIDS (London, England)|July 19, 2006
Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapyAsha R Kallianpur, Todd Hulgan, Jeffrey A Canter, et al.
The Pharmacogenomics Journal|August 9, 2007
The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathyJ A Canter, D W Haas, A R Kallianpur, et al.
Pageof 34